Table 1.
Peptides previously designed and evaluated for their antimicrobial capacity under the mentioned methods where MD corresponds to molecular dynamics, DL to Deep Learning and MF to Microfluidics.
| Peptide | Amino Acid Sequence | Biological Activity | Method |
|---|---|---|---|
| CAMEL0 [243] | KWKLFKKIGAVLKVL | Antimicrobial | MD |
| CAMEL17 [243] | KWNLNGNINAVLKVL | Antimicrobial | MD |
| LL-37 [175] | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | Antimicrobial | MD |
| AcrAP1 [244] | FLFSLIPHAISGLISAFK | Antimicrobial | MD |
| Chrys-3 [177] | FIGLLISAGKAIHDLIRRRH | Antimicrobial | MD |
| Pin2 [245] | FWGALAKGALKLIPSLFSSFSKKD | Antimicrobial | MD |
| Melittin [246] | GIGAVLKVLTTGLPALISWIKRKRQQ | Antimicrobial | MD |
| Putative Bacteriocin 3 [247] | IKKIGKKAAKKVIVKAIQAI | Antimicrobial | DL |
| Putative Bacteriocin 4 [247] | KKIGKKAAKKVIVKAIQAIV | Antimicrobial | DL |
| RaCa-1 [116] | GLLDIIKTTGKDFAVKILDNLKCKLAGGCPP | Antimicrobial | DL |
| RaCa-2 [116] | FFPIIARLAAKVIPSLVCAVTKKC | Antimicrobial | DL |
| RaCa-3 [116] | GLWETIKTTGKSIALNLLDKIKCKIAGGCPP | Antimicrobial | DL |
| RaCa-7 [116] | FFPRVLPLANKFLPTIYCALPKSVGN | Antimicrobial | DL |
| Cecropin A [248] | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2 | Translocating/Antimicrobial | MF |
| Cecropin B [228] | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL-NH2 | Antimicrobial | MF |
| Smp43 [249] | GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS | Antimicrobial | MF |
| Cinnamycin [250] | CRQSCSFGPFTFVCDGNTK | Antimicrobial | MF |
| RWRWR [218] | Ac-RWVRVpGO(FAM)WIRQ-NH2 | Traslocating | MF |
| OWRWR [218] | Ac-OWVRVpGO(FAM)WIRQ-NH2 | Traslocating | MF |